MGP is upregulated in primary colorectal cancer (CRC) and liver metastases, where it increases intracellular free Ca2+ and NF-κB phosphorylation, activating PD-L1 and promoting CD8+ T cell exhaustion (56). Here, MGP is linked to colorectal carcinoma.